Jeffrey A. Meckler, Director at Travere Therapeutics, Inc. (TVTX), sold 20,000 shares at $65.39 ($1.3M) on 2026-09-10, disclosed to the SEC on 2026-09-11.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.39 | 1,700 | $111K | 8.3% |
| 2 | $66.15 | 1,200 | $79K | 5.9% |
| 3 | $67.46 | 14,000 | $944K | 70.2% |
| 4 | $68.09 | 3,100 | $211K | 15.7% |
| Total | $67.31 avg | 20,000 | $1.3M | 100% |
| Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |
| INDP | BUY | 2022-09-08 | $25K | — | Filing → |